• Home

  • Cannabis

  • Resource

  • Health/Biotech

  • Tech/Special Sits

  • All Client News

  • Contact

  • More

    Use tab to navigate through the menu items.
    • Home

    • Cannabis

    • Resource

    • Health/Biotech

    • Tech/Special Sits

    • All Client News

    • Contact

    • More...

      Use tab to navigate through the menu items.
      FRONTIER-MCG.jpg
      • May 11
      • 5 min
      Health | Biotechnology

      Rakovina Presents Preclinical Data at the 2022 AACR Special Conference on Sarcomas

      Rakovina highlighted the development of its kt-3000 drug candidates as a potential treatment of Ewing sarcoma and other soft tissue tutors..

      • May 9
      • 5 min
      Health | Biotechnology

      Resverlogix Announces Type C Meeting with FDA for Phase 3 High-risk COVID-19 Outpatient Study

      FDA has granted the request for a meeting to review the clinical trial protocol for its Phase 3 study in high-risk COVID-19 outpatients.

      • May 9
      • 3 min
      Health | Biotechnology

      Aduro Joins Canada Plastics Pact as a Signatory Partner

      The CPP brings together businesses, policy makers, and NGOs to work together and create a national solution to plastic waste and pollution..

      • Apr 14
      • 1 min
      Health | Biotechnology

      InvestmentPitch Media: Rakovina Therapeutics committed to advancing new cancer therapies

      • Apr 13
      • 4 min
      Health | Biotechnology

      Rakovina Presents at the American Association of Cancer Research (AACR) Annual General Meeting..

      The data presented suggested promising activity for bi-functional kt-4000 series compounds...

      • Mar 30
      • 3 min
      Health | Biotechnology

      Rakovina Therapeutics to Present Abstract at the 2022 AACR Special Conference – Sarcomas

      Rakovina’s presentation will highlight the development of its drug candidates as a potential treatment of sarcomas and soft tissue tumors..

      • Mar 17
      • 6 min
      Health | Biotechnology

      Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal..

      he article outlines the positive impact of apabetalone in the investigator-led pulmonary arterial hypertension (PAH) pilot study, APPRoAcH-p

      • Mar 9
      • 3 min
      Health | Biotechnology

      Rakovina to Present at the 2022 Annual Meeting of the American Association of Cancer Research (AACR)

      Rakovina Therapeutics presentation will highlight pre-clinical research related to its novel kt-4000 series.

      • Mar 1
      • 1 min
      Health | Biotechnology

      Rakovina Therapeutics Inc. TSXV: RKV

      • Mar 1
      • 1 min
      Health | Biotechnology

      The Market Herald: Resverlogix (TSX:RVX) steps up Phase 2b study for COVID-19 treatment

      1
      2345

      Toronto | Montreal | Calgary | Vancouver

      ​

      https://www.frontiermcg.com

      About Us